biological marker; convalescent plasma; D dimer; endogenous compound; ferritin; oxygen; procalcitonin; remdesivir; aged; all cause mortality; anonymised data; Asia; Australia; cancer patient; clinical evaluation; conference abstract; controlled study; coronavirus disease 2019; diabetes mellitus; diagnosis; drug therapy; Europe; female; human; hypertension; lung disease; major clinical study; male; mortality; mortality rate; multicenter study; North America; outcome assessment; pancytopenia; retrospective study; risk factor; South America